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Background
Reperfusion of the myocardium is imperative to limit
the damage caused, by occlusion of an artery following
myocardial infarction (MI). However, restoration of
blood flow to the ischaemic tissue causes damage itself,
a phenomenon known as reperfusion injury. Modifying
cellular processes at early reperfusion can reduce the
irreversible cell damage caused. The reperfusion injury
salvage kinase (RISK) pathway, an endogenous signalling
pathway that is activated during early reperfusion to
limit lethal damage is a pharmacological target. Soluble
guanylyl cyclase (sGC) – cyclic guanosine monopho-
sphate (cGMP) is a component of the RISK pathway.
Previous studies have shown that the cGMP analogue
8Br-cGMP limits infarct size when given at reperfusion
in an experimental model of MI [1]. We therefore
hypothesised that administration of the sGC stimulator
BAY 412272 or the sGC activator BAY 602770 at reper-
fusion would be cardioprotective, limiting infarct size.
Materials and methods
Hearts from male Sprague-Dawley rats (300-350g) were
Langendorff perfused with modified Krebs-Henseleit
buffer at constant pressure (74mmHg) [2]. After a per-
iod of stabilisation hearts were subjected to 35min
regional ischaemia by temporarily occluding the left des-
cending coronary artery. At 30 min ischaemia, BAY
412272 or BAY 602770 were perfused for 15 min (10
min into reperfusion). Control hearts were perfused
w i t ht h es a m eb u f f e ri nt h ea b s e n c eo ft h ed r u g .T o
further characterise the infarct limiting properties of
BAY 412272 and BAY 602770, further Langendorff
experiments were carried out in which the sGC inhibitor
ODQ was perfused with or without BAY 412272 and
ODQ with or without BAY 602770. Following reperfu-
sion hearts were frozen, sliced into disks and stained
with triphenyltetrazolium chloride and infarct size was
expressed as a percentage of the ischaemic risk zone. To
confirm that BAY 412272 elevated cGMP, radioimmu-
noassay was carried out on myocardial tissue samples
perfused with BAY 412272 at early reperfusion.
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Figure 1 Infarct size data (A-D)o fh e a r t sp e r f u s e dw i t hs G C
stimulator BAY 412272 3 µM unless specified, BAY 602770 5 nM
unless specified and ODQ 2 µM. cGMP measurements (E)o f
myocardial left ventricular (LV) and right ventricular (RV) tissue
samples treated with and with without BAY 412272 3 µM at 10 min
reperfusion. Data are expressed as mean ± SEM, * p<0.05, vs.
Control, ** p<0.01, vs. Control (A-D) and ** p<0.01 vs. LV without
BAY, ## p< 0.01 vs. RV without BAY (E), n≥6 (One-way ANOVA).
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See Figure 1.
Conclusion
T h ed a t ai nF i g u r e1s h o w st h a tb o t hB A Y4 1 2 2 7 2a n d
BAY 602770 afford infarct limitation when given at
early reperfusion. Protection afforded by BAY 412272
requires the presence of the reduced haem moiety, con-
versely to BAY 602770. We also show that BAY 412272
elevates cGMP levels in early reperfusion following 35
min left descending coronary artery occlusion. The com-
plex redox balance in early reperfusion following ischae-
mic insult makes these redox sensitive compounds
useful tools when targeting the sGC-cGMP pathway,
showing potential for the therapeutic treatment of MI.
Published: 1 August 2011
References
1. Burley DS, Baxter GF: Post-conditioning is dependent on PKG activation
in early reperfusion. J Mol Cell Cardiol 2005, 38:1008-1009.
2. Burley DS, Baxter GF: B-type natriuretic peptide at early reperfusion limits
infarct size in the rat isolated heart. Basic Res Cardiol 2007, 102:529-541.
doi:10.1186/1471-2210-11-S1-P8
Cite this article as: Bice and Baxter: Targeting of soluble guanylyl
cyclase limits infarct size in a model of acute myocardial infarction. BMC
Pharmacology 2011 11(Suppl 1):P8.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Bice and Baxter BMC Pharmacology 2011, 11(Suppl 1):P8
http://www.biomedcentral.com/1471-2210/11/S1/P8
Page 2 of 2